Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Multimodal therapy concepts have been successfully implemented in the treatment of locally
advanced gastrointestinal malignancies. The effects of neoadjuvant chemo-or …

Neoadjuvant therapy has been successfully introduced in the treatment of locally advanced
gastrointestinal malignancies, particularly esophageal, gastric, and rectal cancers. The …

Objective: An increasing number of patients with locally advanced gastric carcinomas (GC)
are being treated with preoperative chemotherapy before surgery. Background …

INTRODUCTION: Preoperative chemotherapy (CT) and preoperative chemoradiation
therapy (CRT) for resectable oesophageal cancer have been shown to improve overall …

Esophageal and Esophagogastric Junction Cancers in: Journal of the National
Comprehensive Cancer Network Volume 9 Issue 8 (2011) Jump to Content User Account …

Background This multicentre cohort study sought to define a robust pathological indicator of
clinically meaningful response to neoadjuvant chemotherapy in oesophageal …

Introduction Major pathologic regression after neoadjuvant therapy is a strong and favorable
prognostic factor in several types of cancer (breast, rectal and bladder). This information is …

Background The aim of this study was to evaluate the impact of pathologic complete
response (pCR) on outcome in patients with gastric or esophagogastric junction (EGJ) …

The treatment results of patients with locally advanced esophageal carcinomas have
evolved since the publication of the first trial of concurrent mitomycin C and 5-fluorouracil …